FEB 03, 2016 10:30 AM PST

Assessment of animal welfare risks for externalized animal studies by partnering diligence and scientific review at GlaxoSmithKline

Speaker

Abstract

Animal studies performed on behalf of GlaxoSmithKline (GSK) are expected to uphold the core principles established by Corporate Policy 403, ‘Care, Welfare and Treatment of Animals by GSK’.  There are two major considerations that are assessed prior to approval of an external institution; conformance with all 8 principles for animal care and use, and an assurance of a scientific peer review.   The diligence reviews are composed of a set of electronic forms that are completed by the GSK scientists and the partnering external institution.  These forms include information about the institution, aspects of ethical review and details of the study.  Specific review is weighted based on species order, the regulatory oversight in the country of work, the level of pain/distress in the study design and any previous history with the institution.  Studies involving unalleviated pain, plus any study involving non-rodent species are forwarded to the team of expert scientists that provide a peer review.  The need for a site visit is determined by a risk rating tool that highlights the potential welfare concerns for the company.  Partnering these two processes, diligence and scientific review, meets the expectations for quality and risk assessment for external institutions at GSK.

Learning Objectives:
•    To understand the perceived animal welfare risks that externalized studies pose for GSK
•    To understand the components and process of the diligence and scientific reviews 
•    To share our risk rating tool for determination of necessary site visits


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
FEB 03, 2016 10:30 AM PST

Assessment of animal welfare risks for externalized animal studies by partnering diligence and scientific review at GlaxoSmithKline


Specialty

Animal Research

Cell Culture

Immunology

Cancer Research

Tumor

Biomarkers

Cancer

Staphylococcus (Staph Infection)

Earth Science

Oncology

Pharmacology

University

Gene Sequencing

Clinical Chemistry

Animal Welfare

Geography

Europe50%

North America17%

Asia17%

Registration Source

Website Visitors100%

Job Title

Medical Laboratory Technician40%

Research Scientist40%

Student20%

Organization

Academic Institution33%

Pharmaceutical Company17%

Manufacturer - Other17%

Research Institute17%


Show Resources
Loading Comments...
Show Resources